Results 81 to 90 of about 130,554 (162)

VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body

Scientific Reports, 2017
Only free drugs have been believed to be carried into tissues through active or passive transport. However, considering that lipoproteins function as carriers of serum lipids such as cholesterol and triglycerides, we hypothesized that lipoproteins can ...
Hideaki Yamamoto, Tappei Takada, Yoshihide Yamanashi, Masatsune Ogura, Yusuke Masuo, Mariko Harada-Shiba, Hiroshi Suzuki   +6 more
doaj   +1 more source

Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomised controlled trial [PDF]

, 2017
Aims To determine the clinical impact of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a) > 500 mg/L on the primary end point of quantitative myocardial perfusion, as well as secondary end points including atheroma ...
Arai, AE, Rhodes, S, Hsu, LY, Wage, R, Alison Pottle, Li-Yueh Hsu, Andrew E. Arai, Pennell, DJ, Samantha Rhodes, Khan, TZ, Collins, P, Tina Z. Khan, Dudley J. Pennell, Winston Banya, Shivraman Giri, Ricardo Wage, Barbir, M, Peter D. Gatehouse, Gatehouse, PD, Banya, W, Giri, S, Mahmoud Barbir, Pottle, A, Peter Collins   +23 more
core   +1 more source

Lipid and lipoprotein (Low Density Lipoprotein) apheresis in pregnancy [Lipidoaferesi ed LDL-aferesi in gravidanza]

, 2012
Pregnancy and delivery in a women with a severe genetically determined hyperlipidemia is a rare event, but not impossible. Increasing morbidity and mortality of both mother and child due to severe hyperlipidemia already existing, or induced by change of ...
MOROZZI, CLAUDIA, CAPRI, Oriana, STEFANUTTI, Claudia, PERRONE, Giuseppina   +3 more
core  

Long-term efficacy of lipoprotein apheresis in the management of familial hypercholesterolaemia: Application of two different apheresis techniques in childhood

, 2016
Lipoprotein apheresis is used to treat patients with familial hypercholesterolemia (FH). The aim of the present study is to clarify the lipoprotein apheresis procedure performed by cascade filtration (CF) or double filtration plasmapheresis (DFPP) on ...
KENDİRCİ, Mustafa, ÇETİN, Aysun, Ustkoyuncu, Pembe Soylu, Solmaz, Musa, KAYNAR, Leylagül, Gokay, Songül, KARDAŞ, Fatih   +6 more
core   +1 more source

Lipoprotein Apheresis Acutely Reverses Coronary Microvascular Dysfunction in Patients With Severe Hypercholesterolemia [PDF]

, 2019
OBJECTIVES:This study evaluated whether lipoprotein apheresis produces immediate changes in resting perfusion in subjects with severe hypercholesterolemia, and whether there is a difference in the response between peripheral and coronary ...
Federico Moccetti, P. Barton Duell, Wu, Melinda D, Sotirios Tsimikas, Giraud, George, Brian P. Davidson, Eran Brown, Hagai Tavori, Lindner, Jonathan R, Melinda D. Wu, Moccetti, Federico, Fazio, Sergio, Tamara Atkinson, Belcik, J Todd, Atkinson, Tamara, Brown, Eran, Sergio Fazio, Davidson, Brian P, Tsimikas, Sotirios, Tavori, Hagai, George Giraud, Duell, P Barton, J. Todd Belcik, Jonathan R. Lindner   +23 more
core   +1 more source

Effects of weekly LDL-apheresis on metabolic parameters of apolipoprotein B in heterozygous familial hypercholesterolemia

Journal of Lipid Research, 1996
Apheresis is a treatment option for patients with severe hypercholesterolemia and coronary artery disease. It is, however, unknown whether such therapy changes kinetic parameters of lipoprotein metabolism, such as apolipoprotein B (apoB) secretion rates,
K G Parhofer, P H Barrett, T Demant, W O Richter, P Schwandt   +4 more
doaj   +1 more source

Therapeutic apheresis in low weight patients: technical feasibility, tolerance, compliance, and risks

, 2004
The use of therapeutic apheresis in very low weight patients is generally thought to have limitations, because of possible severe adverse reactions, potential risk related to the extracorporeal procedure, due to the low weight of the young patients.
Di Giacomo S., Lanti A., De Lorenzo F., ISACCHI, GIANCARLO, Stefanutti C., Lanti A., Di Giacomo S., Mareri M., De Lorenzo F., Landolfo A., Isacchi G., Landolfo A., Stefanutti C., Mareri M.   +7 more
core   +1 more source

Management of Pregnancy in a Patient with Familial Hypercholesterolemia and Previous Myocardial Infarction—Treatment with LDL Apheresis: A Case Report

Reports
Familial hypercholesterolemia, a genetic disorder marked by elevated low-density lipoprotein cholesterol (LDL-C), poses significant risks for premature atherosclerosis and cardiovascular diseases, particularly during pregnancy. One of the safe methods of
Milos Milincic, Jovana Todorovic, Stefan Dugalic, Ivana Novakovic, Maja Macura, Katarina Lalic, Miroslava Gojnic Dugalic   +6 more
doaj   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source